CD274 and colorectal carcinoma: To this end, overexpression of PD‐L1 in CRC is associated with immune escape and poor prognosis.[6] To unravel the full potential of anti‐PD immunotherapy, intensive research has been conducted to elucidate the mechanisms underlying these de novo and adaptive resistance and to identify new strategies for their circumvention.